Medium

Aria Pharmaceuticals

Aria Pharmaceuticals

·

Dec 19, 2022

More Progress, with More Confidence

By: Andrew A Radin, CEO & Co-founder, Aria Pharmaceuticals

Aria Pharmaceuticals

·

Nov 9, 2022

We Must Unblock the Sharing of Data

By: Aaron C. Daugherty, VP of Discovery, Aria Pharmaceuticals

Aria Pharmaceuticals

·

Mar 16, 2022

Moving the dialogue forward: The need for better AI integration in drug discovery

By: Andrew A Radin, CEO & Co-founder, Aria Pharmaceuticals

Moving the dialogue forward: The need for better AI integration in drug discovery

Aria Pharmaceuticals

·

Dec 14, 2021

A Transformational Year for Aria

By: Andrew A Radin

A Transformational Year for Aria

Aria Pharmaceuticals

·

Sep 30, 2021

A New Era of Hope for Idiopathic Pulmonary Fibrosis

By: Anjali Pandey, Ph.D.

A New Era of Hope for Idiopathic Pulmonary Fibrosis

Aria Pharmaceuticals

·

May 26, 2021

What’s In A Name? Artistry and Sound Science!

By: Andrew A. Radin

What’s In A Name? Artistry and Sound Science!

Aria Pharmaceuticals

·

Mar 31, 2021

R&D Is Changing And I’m On Board

by: Mark Eller, Ph.D. SVP of R&D, twoXAR

R&D Is Changing And I’m On Board

Aria Pharmaceuticals

·

Jan 21, 2021

This Year’s JPM Healthcare Conference Should Give Our Industry Confidence

Andrew A. Radin CEO, twoXAR Pharmaceuticals

This Year’s JPM Healthcare Conference Should Give Our Industry Confidence

Aria Pharmaceuticals

·

Dec 16, 2020

Looking forward to 2021 at twoXAR

Andrew A. Radin CEO, twoXAR Pharmaceuticals

Looking forward to 2021 at twoXAR

Aria Pharmaceuticals

·

Oct 28, 2020

Why twoXAR Pharmaceuticals isn’t working on COVID-19

by: Andrew A. Radin CEO, twoXAR

Why twoXAR Pharmaceuticals isn’t working on COVID-19

Aria Pharmaceuticals

Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex diseases.

Following

Help

Status

About

Careers

Press

Blog

Store

Privacy

Rules

Terms

Text to speech